A decrease in albumin in early SIV infection is related to viral pathogenicity

Susan M Graham1, Sarah Holte, Jason T Kimata

  • 1Department of Medicine, University of Washington, Seattle, Washington 98104, USA. grahamsm@u.washington.edu

Insights

Decreased albumin levels in pig-tailed macaques indicate Simian Immunodeficiency Virus (SIV) infection progression. The extent of albumin decrease correlates with the pathogenicity of the infecting SIV strain.

Area of Science:

  • Veterinary Immunology
  • Virology
  • Primate Models

Background:

  • Circulating albumin decrease predicts disease progression in HIV-infected adults.
  • Simian Immunodeficiency Virus (SIV) infection in macaques serves as a model for HIV pathogenesis.

Purpose of the Study:

  • To investigate if albumin levels decrease in pig-tailed macaques during early SIV infection.
  • To determine if the degree of albumin decrease relates to the pathogenicity of the infecting SIV strain.

Main Methods:

  • Ten juvenile pig-tailed macaques were inoculated with SIV variants of varying pathogenicity.
  • Albumin levels were measured in stored serum samples.
  • Statistical analyses included paired t tests and generalized estimating equations (GEE) modeling.

Main Results:

  • Albumin levels decreased significantly post-SIV inoculation and during chronic infection.
  • A significant difference in albumin decrease was observed between infections with early/intermediate versus late SIV variants.
  • The magnitude of albumin decrease was more pronounced with more pathogenic SIV strains.

Conclusions:

  • Albumin levels decrease in both early and chronic SIV infection in macaques.
  • The observed changes in albumin are influenced by the pathogenicity of the infecting SIV strain.
  • These findings highlight the utility of albumin as a biomarker in SIV pathogenesis studies.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...